Proteomic identification of nitrated proteins in Alzheimer's disease brain.
about
Oxidative Stress Signaling in Alzheimers DiseaseFunctional analysis of the promoter of the mitochondrial phosphate carrier human gene: identification of activator and repressor elements and their transcription factorsNitric oxide and peroxynitrite in health and diseaseInvolvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's diseasePeroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in ratsPhosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and CognitionHeat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseasesThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentThe roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic reviewInsight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingProteomics of protein post-translational modifications implicated in neurodegenerationRecent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiologyMass spectrometry-based methods for identifying oxidized proteins in disease: advances and challengesMechanisms of peroxynitrite interactions with heme proteinsMutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implicationProtein 3-nitrotyrosine in complex biological samples: quantification by high-pressure liquid chromatography/electrochemical detection and emergence of proteomic approaches for unbiased identification of modification sitesRoles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.When is mass spectrometry combined with affinity approaches essential? A case study of tyrosine nitration in proteins.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis.NADPH oxidase as a therapeutic target in Alzheimer's disease.Protein carbonyl formation in the diaphragm.Structural characterisation of tyrosine-nitrated peptides by ultraviolet and infrared matrix-assisted laser desorption/ionisation Fourier transform ion cyclotron resonance mass spectrometry.Proteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging.Protein nitration with aging in the rat semimembranosus and soleus muscles.Identification of non-Alzheimer's disease tauopathies-related proteins by proteomic analysis.Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.In vitro and in vivo protein-bound tyrosine nitration characterized by diagonal chromatographyOxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobuleEndogenous 3,4-dihydroxyphenylalanine and dopaquinone modifications on protein tyrosine: links to mitochondrially derived oxidative stress via hydroxyl radicalInvolvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.Irradiation enhances hippocampus-dependent cognition in mice deficient in extracellular superoxide dismutase.Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegenerationBiliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Conformational altered p53 as an early marker of oxidative stress in Alzheimer's diseaseProtein aggregation and degradation mechanisms in neurodegenerative diseasesLack of p53 affects the expression of several brain mitochondrial proteins: insights from proteomics into important pathways regulated by p53.
P2860
Q22241327-9B9EFECF-EE9C-4B93-AEF3-83D2910C6851Q24537155-AEFFDF2C-AEEB-4748-939E-76C162C6613EQ24645400-9B5361EF-A2CE-49E5-B72C-FAE6269251E0Q24684559-97076F10-D7E5-4B20-AB41-A82EFA36DD75Q24807077-F3034D37-1766-4409-AAC5-D444206884ADQ26771954-87E13DE7-7E85-4FB3-9D0C-B854B520A63EQ26778791-81275D4B-63B6-4D39-A561-A79E6B4DC768Q26827320-C5DA6BED-99CE-434B-A994-19F3AF1CA960Q27008396-3ADFFCF8-9333-4DFB-BCE7-772432DED340Q28076999-9DCD8BA9-8883-4576-BDDF-9C042698DC81Q28088631-AC808CBB-2F26-4BF8-8421-30BFD3F06F8FQ28260273-54942A17-BD3E-48C1-958C-F8EBE47B0E9AQ28382957-175D0988-108D-43C4-A5D5-56335693A9E6Q28397657-761896B3-B740-4844-9A5C-0C9FDCB43FA0Q28510031-81FFB350-21B2-4B41-8D0F-002A9565FDA8Q30369979-C10FFB89-E7CC-42AF-B86A-FCB098B3F500Q30394816-81693A03-D5F3-44FF-BB2D-9E0769E60763Q30420482-D62C966F-05F3-432F-BFD5-C965920103B1Q30446460-D2521346-6755-481F-BE28-40C3776E5292Q30777447-8ACA5A9A-8F8D-46D1-B27D-E886EA6FC0B3Q30855129-11BB2529-4975-4815-832F-8639C77A73C5Q31119371-52B59E52-5E7C-432A-9FEE-9C34072046D4Q33228339-DEC7D7DE-49F4-400F-9881-DFE873379AE7Q33239791-C42345B6-26C1-4567-AD84-E12DE7C213A7Q33254107-427BEAD5-BB70-4FC3-8781-BFC8BEDCB8FDQ33353893-F8AC4D27-651B-4887-A6E6-C941FAE31EB4Q33506441-2EEE9B35-CF53-428A-8326-F000EA3F4C5DQ33555956-44C4FE95-8103-404D-86A2-8AF984AAEDDAQ33588687-4C50D28A-B9AE-4332-8DD6-9FA9F3236770Q33628873-BC75CAA4-FCC7-4640-B6F2-04A40E88BBDBQ33639885-7EEBE769-8529-4B40-95A3-7807CDDA74A4Q33643522-8E10F40A-81FE-4994-A9C5-1FBF91685CACQ33883022-0C1E105A-2E4F-431C-A034-CD4D9285E12CQ33915362-F329D1EC-1C4F-466F-8DCD-DECD0C1E0BA6Q33937186-F7C89771-4EA1-4BE0-BA76-2902FEAA873AQ34071097-FB7BF653-28CA-4032-B0A1-45E757811591Q34094516-F26707D3-8C74-4563-8DFE-5DC954CB8B30Q34126651-364F86E3-5857-495F-A1DB-015EC58D6F2FQ34334363-E323FF7A-9338-4254-882B-967F6250844DQ34499763-38A0621C-14E2-49CE-B2B8-3B2A1990F4CE
P2860
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
@ast
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
@en
type
label
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
@ast
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
@en
prefLabel
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
@ast
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
@en
P2093
P2860
P1476
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
@en
P2093
Alessandra Castegna
Jon B Klein
William R Markesbery
P2860
P304
P356
10.1046/J.1471-4159.2003.01786.X
P407
P577
2003-06-01T00:00:00Z